SEC Form 4 · accession 0001209191-18-011789
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine D. Strader
Director
Period of report
Feb 17, 2018
Accepted (ET)
Feb 21, 2018 · 8:19 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1 | $25.80 | Feb 17, 2018 | A | 4,974 | A | — | May 17, 2028 | Common Stock | 4,974 | 4,974 | D |
Explanation of responses
- F1The shares subject to this option vest in four equal quarterly installments over 12 months with the first quarterly installment vesting on 5/17/2018.